Bryhali Approval Status
FDA Approved: No (Pending Approval)
Brand name: Bryhali
Generic name: halobetasol propionate
Dosage form: Lotion
Previous Name: Jemdel
Company: Ortho Dermatologics
Treatment for: Plaque Psoriasis
Bryhali (halobetasol propionate) is a high-potency topical steroid formulation in development for the treatment of plaque psoriasis.
Development Status and FDA Approval Process for Bryhali
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.